Jose Ricardo Lopez Castellanos
Researcher
Formerly Arkansas Affiliated with UAMS through 2021; recent publications list Medical University of South Carolina.
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jose Ricardo Lopez Castellanos' research focuses on neurological disorders and their treatments, as well as medical case studies. His recent publications investigate the therapeutic effects of OnabotulinumtoxinA in conditions such as harlequin syndrome, episodic migraine, and piriformis syndrome. He has also published on the management of orthostatic hypotension and the remission of symptoms in Lance-Adams syndrome. His work includes evaluating the impact of online resources on neurology residency applications. Lopez Castellanos has a total of four publications and remains recently active in his field.
Metrics
- Publications: 4
Selected Publications
-
#HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125) (2021)
-
Complete remission of symptoms in a case of Lance-Adams syndrome: A 17-year follow-up (2021)
-
Therapeutic effect of OnabotulinumtoxinA in harlequin syndrome and episodic migraine: A case report (2021)
-
Therapeutic effect of onabotulinumtoxina (BONT/A) in piriformis syndrome resistant to conventional therapy (2021)
Collaboration Network
Top Collaborators
- Therapeutic effect of onabotulinumtoxina (BONT/A) in piriformis syndrome resistant to conventional therapy
- Therapeutic effect of OnabotulinumtoxinA in harlequin syndrome and episodic migraine: A case report
- Complete remission of symptoms in a case of Lance-Adams syndrome: A 17-year follow-up
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
- #HowToNeuroTwitter: Evaluating the Impact of a Comprehensive #NeuroTwitterNetwork Guide for the 2020–2021 Neurology Residency Application Cycle (1125)
Similar Researchers
Based on overlapping research topics